Abbott Laboratories
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $11,459,000 | $11,369,000 | $11,142,000 | $10,358,000 |
Gross Profit | 6,537,000 | 6,338,000 | 6,288,000 | 5,444,000 |
EBITDA | 2,524,000 | 3,092,000 | 3,048,000 | 2,668,000 |
EBIT | 2,102,000 | 2,301,000 | 2,271,000 | 1,912,000 |
Net Income | 1,776,000 | 1,644,000 | 1,779,000 | 1,325,000 |
Net Change In Cash | 11,459,000 | 11,369,000 | 11,142,000 | 10,358,000 |
Free Cash Flow | 2,291,000 | 1,545,000 | 933,000 | |
Cash | 7,511,000 | 6,951,000 | 6,532,000 | |
Basic Shares | 1,747,000 | 1,749,000 | 1,751,000 | 1,747,220 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $44,328,000 | $41,950,000 | $40,109,000 | $43,653,000 |
Gross Profit | 24,607,000 | 21,325,000 | 20,037,000 | 22,323,000 |
EBITDA | 11,332,000 | 10,834,000 | 10,605,000 | 11,888,000 |
EBIT | 8,586,000 | 7,616,000 | 7,362,000 | 8,621,000 |
Net Income | 6,524,000 | 13,402,000 | 5,723,000 | 6,933,000 |
Net Change In Cash | 44,328,000 | 41,950,000 | 40,109,000 | 43,653,000 |
Cost of Revenue | 205,000 | |||
Free Cash Flow | 6,351,000 | 5,059,000 | 7,804,000 | |
Cash | 7,616,000 | 6,896,000 | 9,882,000 | |
Basic Shares | 1,747,000 | 1,748,000 | 1,749,000 | 1,764,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $1.50 |
2025-09-30 | $1.30 |
2025-06-30 | $1.26 |
2025-03-31 | $1.09 |
